Breast-feeding. SSRIs and TCAs are excreted into
breast milk, and low concentrations have been found
in infants ’serum. Plasma levels of the SSRIs paroxetine
and sertraline in breast-fed infants are usually
undetectable. In mothers receiving SSRIs and TCAs
(with the exception of doxepine), it seems unwarranted
to recommend that breast-feeding should be
discontinued. During maternal treatment with benzodiazepines,
infants should be observed for signs of
sedation, lethargy, poor suckling, and weight loss,
and if high doses have to be used and long-term
administration is required, breast feeding should
probably be discontinued.